Stable drug formulation, including components of relapsing pulmonary surfactant

摘要

A physically and chemically stable pharmaceutical preparation in the form of water suspension, including a reconstituted pulmonary surfactant. This formulation is suitable for the prevention and / or treatment of dyspnea syndrome or other respiratory disorders. D. Claim 12: ways to avoid an increase in the amount claimedThe storage viscosity of a pharmaceutical formulation is a reconstituted aqueous suspension of pulmonary surfactant components, including phospholipids, plus SP-C and SP-B synthetic analogs of proteinsIt is characterized in that it includes pH adjustment between 6.4 and 7.6 with appropriate buffer.